Chairperson(s) : Thierry BRUE, Gérald RAVEROT
Que faire en cas de premier dépistage négatif à la recherche d'une cause génétique de tumeur hypophysaire agressive ou précoce ?
Pauline ROMANET, MarseilleQue faire au-delà du témozolomide en cas de tumeur hypophysaire agressive ?
Gérald RAVEROT, LyonMaladie de Cushing à image incertaine : faut-il opérer ?
Bertrand BAUSSART, ParisChairperson(s) : Philippe CHANSON, Nabila REKIB-MEJDOUB
Adénome thyréotrope géant : quand la collaboration endocrinologie-Neurochirurgie fait la différence
Fatma MNIF, Sfax, TUNISIAMétamorphose phénotypique d’un Incidentalome hypophysaire non sécrétant en macroprolactinome géant et paradoxe radiobiologique : une double singularité évolutive
Khouloud BOUJELBEN, Sfax, TUNISIAMaladie de Cushing et « kissing carotids » : un défi neurochirurgical face à une variante anatomique à haut risque
Ibticem BEN NACEF, Tunis, TUNISIAChairperson(s) : Harriet SCHELLEKENS, Uberto PAGOTTO
Preclinical developments
Daniela LISKIEWICZ, , GERMANYNon-obesity effects of GLP-1 agonists (smoking and alcohol abuse)
Kruse Klausen METTE, , DENMARKEfficacy and side effects of GLP-1 agonists
Pagotto UBERTO, , ITALYChairperson(s) : Davide CARVALHO, Krystallenia ALEXANDRAKI
Study on Resistant Prolactinoma
Kristallenia ALEXANDRAKI, , GREECENeuroendocrinology of Reproduction Study Group -Case studies presentation
Paraskevi XEKOUKI, , GREECEParasellar Lesions ENEA European Post Graduate Course
Josanne VASSALLO, , MALTAGH Study Group
Alfonso SOTO, , SPAINACTH Study Group
Mario DETOMAS, , GERMANYTSH Study Group
Federico GATTO, , ITALYPosterior Pituitary Study Group
Cihan ATILA, , SWITZERLANDPlurihormonal Pathology Study Group
Antonio FUENTES-FAYOS, , SPAINAggressive Pituitary Tumors and Pituitary Carcinomas Study Group
Mirela-Diana ILIEChairperson(s) : Jerôme BERTHERAT, Sakina MHAOUTY-KODJA
Effects of exposure to endocrine disrupting chemicals on hypothalamus regulation of reproduction and appetite
Anne-Simone PARENT, , BELGIUMMicrobioma of the mother and development of hypothalamic circuits controlling appetite in the fetus
Sébastien BOURETEffects of a novel set of somatostatin/cortistatin analogues on pituitary neuroendocrine tumors
Federica MANGILI, Milan, ITALYIntegrating genomics, hormone measurements and functional validation in idiopathic hypogonadotropic hypogonadism: insights from a Maltese cohort
Clayton John AXIAK, Msida, MALTAPituitary Developmental Single-cell Mapping Identifies Markers of Heterogeneous High-risk USP8-wildtype Macroadenomas in Cushing’s Disease
Qilin ZHANG, Shanghai, CHINASenescence-associated secretory phenotype characterises aggressive non-functioning pituitary neuroendocrine tumours and is active in SOX2+ tumour stem cell compartments
James KAUFMAN-COOK, London, UNITED KINGDOMMYC inhibition emerges as a potential therapy for fgSRL resistant patients in acromegaly
Paula DE PEDRO-CAMPOS, Badalona, SPAINBeyond Cortisol: Steroid Metabolomics after an Overnight 1‑mg Dexamethasone Test for the Differential Diagnosis of Hypercortisolism
Mario DETOMAS, Würzburg, GERMANYChairperson(s) : Mirela Diana ILIE, Giampaolo TRIVELIN
Transcriptomics of pituitary tumors: molecular classification and clinical implications
Fabio BIOLETTO, , ITALYAdvancing Pituitary Tumor Classifications Through Epigenomic Insights
Matthias DOTTERMUSCH, , GERMANYHyponatremia and the Brain
Julia BECK, , SWITZERLANDChairperson(s) : Justo CASTANO, Krystallenia ALEXANDRAKI
Defining the Cellular Landscape of Multifocal Small Intestine Neuroendocrine Tumors
Netta MÄKINEN, , UNITED STATESPatient derived organoid models help to unveil translational discoveries in neuroendocrine neoplasms: the case of EGF
Talya DAYTON, , SPAINCurrent advances in the treatment of NETs: from targeted therapies to theranostic successes
Simona GLASBERG, , ISRAELChairperson(s) : Peter WOLF, Nicoleta OLARESCU
A targeted proteomic approach reveals plasma biomarkers of active acromegaly
Nicoleta Cristina OLARESCU, Oslo, NORWAYPituitary gigantism is not only a younger form of growth hormone excess but also more aggressive phenotype with increased mortality: a comparison of 290 patients with pituitary gigantism and 2954 patients with acromegaly
Sonia KANIUKA-JAKUBOWSKA, Gdańsk, POLANDEvidencing the safety and efficacy of pegvisomant for children and adolescents with acromegaly: a multicentre retrospective observational study
Kevin A. HUYNH, Cambridge, UNITED KINGDOMProteomic Analysis of GH-secreting and Non Functioning Pituitary Adenomas
Giordana SIRACUSANO, Messina, ITALYLifelong congenital untreated isolated GH deficiency does not alter human telomere length
Júnia R.O.L. SCHWEIZER, Munich, GERMANYLeptin in the regulation of neuroendocrine and immune-metabolic response to energy deprivation in health and disease
Konstantinos STEFANAKIS, Boston, UNITED STATESChairperson(s) : Antoine TABARIN, Marily THEODOROPOULOU
‘Block and replace’ atumelnant (CRN04894) and physiologic hydrocortisone replacement rapidly controls hypercortisolism in ACTH-dependent Cushing syndrome
Alessandra CASAGRANDECirculating MicroRNA Signature in Inferior petrosal Sinus Sampling to Differentiate Patients with ACTH-Dependent Hypercortisolism.
Zhanna BELAYA, Moscow, RUSSIAN FEDERATIONComparative Transcriptome Analysis of ACTH Secreting Pituitary Neuroendocrine Tumors (PitNET) According to USP8 Variant Status
Zhanna BELAYA, Moscow, RUSSIAN FEDERATIONInvestigation of the safety, tolerability, pharmacokinetics, and efficacy of the novel anti-ACTH antibody asedebart in adults with Cushing’s disease: a Phase II, open-label, dose-titration trial
Heike BENECKE, Valby, DENMARKModeling and investigating SOX3 deletions associated with X-linked hypopituitarism using human iPSC-derived pituitary organoids
Giampaolo TRIVELLIN, Pieve Emanuele, ITALYLoss of nuclear menin in non-MEN1 prolactinomas and sex differences: evidence from murine models and human tumors.
Graciela DIAZ-TORGA, Buenos Aires, ARGENTINAChairperson(s) : Dominique MAITER, Marta ARAUJO CASTRO
Specificities in the management of prolactinoma in children and adolescents
Joanne BLAIR, , UNITED KINGDOMShould we change treatment paradigm in young women?
Iris Cm PELSMA, , NETHERLANDSThe different facets of prolactinoma in older patients
Stefan M CONSTANTINESCU, , BELGIUMChairperson(s) : Pina KARDIOGLU, Frédéric CASTINETTI
Corticotroph Tumor development
Luis PEREZ-RIVAS, , GERMANYMolecular Imaging in corticotroph tumors
Linus HABERBOSCH, , GERMANYMedical treatment of Cushing's syndrome: New concepts, new drugs
Rosario PIVONELLO, , ITALY